BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18465026)

  • 21. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of proteasomes in the formation of neurofilamentous inclusions in spinal motor neurons of aluminum-treated rabbits.
    Kimura N; Kumamoto T; Ueyama H; Horinouchi H; Ohama E
    Neuropathology; 2007 Dec; 27(6):522-30. PubMed ID: 18021372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The co-chaperone p23 is degraded by caspases and the proteasome during apoptosis.
    Mollerup J; Berchtold MW
    FEBS Lett; 2005 Aug; 579(19):4187-92. PubMed ID: 16038904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospho-beta-catenin accumulation in Alzheimer's disease and in aggresomes attributable to proteasome dysfunction.
    Ghanevati M; Miller CA
    J Mol Neurosci; 2005; 25(1):79-94. PubMed ID: 15781969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates.
    Kobayashi T; Manno A; Kakizuka A
    Genes Cells; 2007 Jul; 12(7):889-901. PubMed ID: 17584300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of human proteasome assembly chaperone PAC4 involved in proteasome formation.
    Kurimoto E; Satoh T; Ito Y; Ishihara E; Okamoto K; Yagi-Utsumi M; Tanaka K; Kato K
    Protein Sci; 2017 May; 26(5):1080-1085. PubMed ID: 28263418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Backbone ¹H, ¹³C and ¹⁵N assignments of yeast Ump1, an intrinsically disordered protein that functions as a proteasome assembly chaperone.
    Uekusa Y; Okawa K; Yagi-Utsumi M; Serve O; Nakagawa Y; Mizushima T; Yagi H; Saeki Y; Tanaka K; Kato K
    Biomol NMR Assign; 2014 Oct; 8(2):383-6. PubMed ID: 24065419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.
    Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H
    Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis induced by proteasome inhibition in human myoblast cultures.
    Sassone J; Ciammola A; Tiloca C; Glionna M; Meola G; Mancinelli E; Silani V
    Eur J Histochem; 2006; 50(2):109-18. PubMed ID: 16864121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apigenin Reduces Proteasome Inhibition-Induced Neuronal Apoptosis by Suppressing the Cell Death Process.
    Kim A; Nam YJ; Lee MS; Shin YK; Sohn DS; Lee CS
    Neurochem Res; 2016 Nov; 41(11):2969-2980. PubMed ID: 27473386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteome mapping of the Trichoderma reesei 20S proteasome.
    Grinyer J; Kautto L; Traini M; Willows RD; Te'o J; Bergquist P; Nevalainen H
    Curr Genet; 2007 Feb; 51(2):79-88. PubMed ID: 17119969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of dopamine receptors and beta-arrestin in metamphetamine-induced inclusions formation in PC12 cells.
    Fornai F; Lenzi P; Capobianco L; Iacovelli L; Scarselli P; Lazzeri G; De Blasi A
    J Neurochem; 2008 Jun; 105(5):1939-47. PubMed ID: 18266935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CHIP: a co-chaperone for degradation by the proteasome.
    Edkins AL
    Subcell Biochem; 2015; 78():219-42. PubMed ID: 25487024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons.
    Lazzeri G; Lenzi P; Busceti CL; Ferrucci M; Falleni A; Bruno V; Paparelli A; Fornai F
    J Neurochem; 2007 Jun; 101(5):1414-27. PubMed ID: 17286589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dominant-negative effect of mutant valosin-containing protein in aggresome formation.
    Kitami MI; Kitami T; Nagahama M; Tagaya M; Hori S; Kakizuka A; Mizuno Y; Hattori N
    FEBS Lett; 2006 Jan; 580(2):474-8. PubMed ID: 16386250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chaperone-assisted degradation: multiple paths to destruction.
    Kettern N; Dreiseidler M; Tawo R; Höhfeld J
    Biol Chem; 2010 May; 391(5):481-9. PubMed ID: 20302520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of proteasome inhibitors with different chemical structures on the ubiquitin-proteasome system in vitro.
    Csizmadia V; Csizmadia E; Silverman L; Simpson C; Raczynski A; O'Brien L; Gallacher M; Cardoza K; Kadambi VJ; Fedyk ER; Alden CL
    Vet Pathol; 2010 Mar; 47(2):358-67. PubMed ID: 20124009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsm3/S5b joins the ranks of 26S proteasome assembly chaperones.
    Gödderz D; Dohmen RJ
    Mol Cell; 2009 Feb; 33(4):415-6. PubMed ID: 19250902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal DnaJ proteins HSJ1a and HSJ1b: a role in linking the Hsp70 chaperone machine to the ubiquitin-proteasome system?
    Chapple JP; van der Spuy J; Poopalasundaram S; Cheetham ME
    Biochem Soc Trans; 2004 Aug; 32(Pt 4):640-2. PubMed ID: 15270696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy is activated by proteasomal inhibition and involved in aggresome clearance in cultured astrocytes.
    Jänen SB; Chaachouay H; Richter-Landsberg C
    Glia; 2010 Nov; 58(14):1766-74. PubMed ID: 20645412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.